Evidence map›Paper›PMID 27489379›Full record

ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2016

Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients.

Mehmet Akif Camkurt, Fatih Karababa, Mehmet Emin Erdal, Hüseyin Bayazıt, Sultan Basmacı Kandemir, Mustafa Ertan Ay, Hasan Kandemir, Özlem İzci Ay, Erdinç Çiçek, Salih Selek and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. MicroRNAs as biomarkers and molecular mediators of cognitive dysfunction in schizophrenia.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  4. Article
  5. Article
  6. miRNA-Based Diagnosis of Schizophrenia Using Machine Learning.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. miR-132 and miR-942 Expression Levels in Children with Attention Deficit and Hyperactivity Disorder: A Controlled Study.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Mehmet Akif CamkurtPsychiatry Clinic, Afşın State Hospital, Kahramanmaras, Turkey.
Fatih KarababaPsychiatry Clinic, Harran University Teaching Hospital, Şanlıurfa, Turkey.
Mehmet Emin ErdalDepartment of Medical Biology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Hüseyin BayazıtPsychiatry Clinic, Siverek State Hospital, Şanlıurfa, Turkey.
Sultan Basmacı KandemirPsychiatry Clinic, Balıklıgöl State Hospital, Şanlıurfa, Turkey.
Mustafa Ertan AyDepartment of Medical Biology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Hasan KandemirDepartment of Child and Adolescent Psychiatry, Harran University Teaching Hospital, Şanlıurfa, Turkey.
Özlem İzci AyDepartment of Medical Biology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Erdinç ÇiçekPsychiatry Clinic, Çumra State Hospital, Konya, Turkey.
Salih SelekDepartment of Psychiatry and Behavioral Sciences, Harris County Psychiatric Center, University of Texas, Houston, TX, USA.
Bahar TaşdelenDepartment of Biostatistics, Mersin University, Mersin, Turkey.
Mersin Üniversitesi · TRHarran University · TRBalikli Rum Vakfi Hastanesi · TRHarris County Department of Education · USSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe prevalence of schizophrenia is 1%, and it is a debilitating disorder that often results in a shortened lifespan. Peripheral blood samples are good candidates to investigate because they can be easily drawn, and they are widely studied in psychiatric disorders. MicroRNAs are small non-coding RNA transcripts. They regulate the expression of genes by binding to the 3'-untranslated region (UTR) of mRNAs and pointing them to degrade. In this study, we aimed to investigate the expression of miR-9-5p, miR-29a-3p, miR-106-5p, miR-106b-5p, miR-107, miR-125a-3p, and miR-125b-3p in schizophrenia patients and healthy controls.

methodsWe collected blood samples from 16 patients with schizophrenia and 16 healthy controls. MicroRNAs were measured with reverse transcriptase polymerase chain reaction.

resultsSchizophrenia patients showed statistically significant upregulation of five microRNAs: miR9-5p (p=0.002), miR29a-3p (p<0.001), miR106b-5p (p=0.002), miR125a-3p (p<0.001), and miR125b-3p (p=0.018).

conclusionOur results increased the value of the miR106 and miR29 families as potentially and consistently dysregulated in psychiatric disorders. Our results should be considered preliminary, and they need confirmation in future studies with larger sample sizes.

Indexed as

BloodGenesMicroRNAsSchizophrenia

Identifiers

PMID27489379
PMCPMC4977811
OpenAlexW2476020763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.